These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 31161269

  • 1. Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation.
    Kouchak M, Mahmoodzadeh M, Farrahi F.
    AAPS PharmSciTech; 2019 Jun 03; 20(5):210. PubMed ID: 31161269
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.
    Fouda NH, Abdelrehim RT, Hegazy DA, Habib BA.
    Drug Deliv; 2018 Nov 03; 25(1):1340-1349. PubMed ID: 29869516
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gel in core carbosomes as novel ophthalmic vehicles with enhanced corneal permeation and residence.
    Moustafa MA, El-Refaie WM, Elnaggar YSR, Abdallah OY.
    Int J Pharm; 2018 Jul 30; 546(1-2):166-175. PubMed ID: 29778824
    [Abstract] [Full Text] [Related]

  • 9. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
    Ranch KM, Maulvi FA, Naik MJ, Koli AR, Parikh RK, Shah DO.
    Int J Pharm; 2019 Jan 10; 554():264-275. PubMed ID: 30423418
    [Abstract] [Full Text] [Related]

  • 10. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
    Singh J, Chhabra G, Pathak K.
    Drug Dev Ind Pharm; 2014 Sep 10; 40(9):1223-32. PubMed ID: 23837522
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of carbopol-methyl cellulose based sustained-release ocular delivery system for pefloxacin mesylate using rabbit eye model.
    Sultana Y, Aqil M, Ali A, Zafar S.
    Pharm Dev Technol; 2006 Sep 10; 11(3):313-9. PubMed ID: 16895842
    [Abstract] [Full Text] [Related]

  • 12. Preparation and evaluation of HPMC-based pirfenidone solution in vivo.
    Yang M, Yang YF, Lei M, Ye CT, Zhao CS, Xu JG, Wu KL, Yu MB.
    Drug Dev Ind Pharm; 2017 Jan 10; 43(1):171-176. PubMed ID: 27593737
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N, Thakkar V, Metalia V, Baldaniya L, Gandhi T, Gohel M.
    Drug Dev Ind Pharm; 2016 Sep 10; 42(9):1406-23. PubMed ID: 26716613
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhanced ocular efficacy of topically-delivered dorzolamide with nanostructured mucoadhesive microparticles.
    Park CG, Kim YK, Kim SN, Lee SH, Huh BK, Park MA, Won H, Park KH, Choy YB.
    Int J Pharm; 2017 Apr 30; 522(1-2):66-73. PubMed ID: 28216468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.